These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. PfEMP1: an antigen that plays a key role in the pathogenicity and immune evasion of the malaria parasite Plasmodium falciparum. Pasternak ND; Dzikowski R Int J Biochem Cell Biol; 2009 Jul; 41(7):1463-6. PubMed ID: 19150410 [TBL] [Abstract][Full Text] [Related]
17. The hope but challenge for developing a vaccine that might control malaria. Good MF Eur J Immunol; 2009 Apr; 39(4):939-43. PubMed ID: 19350585 [TBL] [Abstract][Full Text] [Related]
18. The varieties of gene amplification, diversification and hypervariability in the human malaria parasite, Plasmodium falciparum. Templeton TJ Mol Biochem Parasitol; 2009 Aug; 166(2):109-16. PubMed ID: 19375460 [TBL] [Abstract][Full Text] [Related]
19. Effects of sex, parity, and sequence variation on seroreactivity to candidate pregnancy malaria vaccine antigens. Oleinikov AV; Rossnagle E; Francis S; Mutabingwa TK; Fried M; Duffy PE J Infect Dis; 2007 Jul; 196(1):155-64. PubMed ID: 17538896 [TBL] [Abstract][Full Text] [Related]
20. Passive transfer of Plasmodium falciparum MSP-2 pseudopeptide-induced antibodies efficiently controlled parasitemia in Plasmodium berghei-infected mice. Martínez PA; Yandar N; Lesmes LP; Forero M; Pérez-Leal O; Patarroyo ME; Lozano JM Peptides; 2009 Feb; 30(2):330-42. PubMed ID: 19071172 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]